MRGPRX2 and stroke disorder: While there is an increase in GFAP in stroke brains as a marker of injury, there is no MRGPRX2 or tryptase expression, suggesting a lack of MRGPRX2-expressing mast cells in the human brain after stroke, consistent with our mouse data (Figure S5A, Table S1).